Advertisement

Role of Tumor Suppressor Genes in a Multistep Model of Carcinogenesis

  • Jeff A. Boyd
  • J. Carl Barrett
Part of the Basic Life Sciences book series (BLSC, volume 57)

Abstract

Most cancers are clonal in origin, arising from a single aberrant cell1. The multistep nature of this process is now a widely accepted paradigm2, and is supported by several lines of evidence from both clinical oncology and experimental models. Among these are: 1) histopathological observations of human tumors reveal multiple stages of tumor progression such as dysplasia and carcinoma in situ3; 2) mathematical models based on age-specific tumor incidence curves are consistent with four to seven independent hits required for tumor formation4; 3) studies of genetic predisposition to cancer in some families suggest that one step in the carcinogenic process is a germline mutation and that additional somatic events are required for full neoplastic development5; 4) well documented experimental systems, including the two-stage model of chemical carcinogenesis in rodent skin6,7 and liver8, show that different chemicals affect qualitatively different stages in the carcinogenic process; 5) cell culture studies reveal that chemical carcinogen-induced neoplastic transformation of normal cells involves a progressive process9; 6) cell culture studies with viral and tumor-derived oncogenes show that the neoplastic conversion of normal cells generally requires multiple cooperating oncogenes10; and 7) studies on the development of tumors in transgenic mice carrying activated proto-oncogenes in their germline indicate that the tumors which arise are clonal in origin, suggesting that additional somatic events besides activation of two cooperating oncogenes are required for full malignant development11.

Keywords

Tumor Suppressor Gene Cell Hybrid Actin Microfilament Restriction Fragment Length Polymorph Retinoblastoma Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    P. C. Nowell, The clonal evolution of tumor cell populations, Science 194:23–28 (1976).PubMedCrossRefGoogle Scholar
  2. 2.
    J. C. Barrett, A multistep model for neoplastic development: Role of genetic and epigenetic changes, in: J. C. Barrett, ed., “Mechanisms of Environmental Carcinogenesis, Vol. II, Multistep Models of Carcinogenesis,” CRC Press, Boca Raton (1987).Google Scholar
  3. 3.
    L. Foulds, “Neoplastic Development,” Academic Press, New York (1975).Google Scholar
  4. 4.
    R. Peto, Epidemiology, multistage models, and short-term mutagenicity tests, in: “Origins of Human Cancer,” H. H. Hiatt, J. D. Watson, and J. A. Winsten, eds., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1977).Google Scholar
  5. 5.
    M. F. Hansen and W. K. Cavenee, Genetics of cancer predisposition, Cancer Res. 47:5518–5527 (1987).PubMedGoogle Scholar
  6. 6.
    R. K. Boutwell, The function and mechanism of promoters of carcinogenesis, CRC Crit. Rev. Toxicol. 2:419–443 (1974).PubMedCrossRefGoogle Scholar
  7. 7.
    T. J. Slaga, S. M. Fischer, K. Nelson, and G. L. Gleason, Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion, Proc. Natl. Acad. Sci. USA 77:3659–3663 (1980).PubMedCrossRefGoogle Scholar
  8. 8.
    E. Farber, The multistep nature of cancer development, Cancer Res. 44:4217–4223 (1984).PubMedGoogle Scholar
  9. 9.
    J. C. Barrett and W. F. Fletcher, Cellular and molecular mechanisms of multistep carcinogenesis in cell culture models, in: “Mechanisms of Environmental Carcinogenesis, Vol. II, Multistep Models of Carcinogenesis,” J. C. Barrett, ed., CRC Press, Boca Raton (1987).Google Scholar
  10. 10.
    D. G. Thomassen, T. G. Gilmer, L. A. Annab, and J. C. Barrett, Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras), Cancer Res. 45:726–732 (1985).PubMedGoogle Scholar
  11. 11.
    E. Sinn, W. Muller, P. Pattengale, I. Tepler, R. Wallace, and P. Leder, Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo, Cell 49:465–475 (1987).PubMedCrossRefGoogle Scholar
  12. 12.
    J. M. Bishop, The molecular genetics of cancer, Science 235:305–311 (1987).PubMedCrossRefGoogle Scholar
  13. 13.
    R. A. Weinberg, The action of oncogenes in the cytoplasm and nucleus, Science 230:770–776 (1985).PubMedCrossRefGoogle Scholar
  14. 14.
    M. B. Sporn and A. B. Roberts, Autocrine growth factors and cancer, Nature 313:745–750 (1985).PubMedCrossRefGoogle Scholar
  15. 15.
    L. F. Parada, C. J. Tabin, C. Shih, and R. A. Weinberg, Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene, Nature 297:474–478 (1982).PubMedCrossRefGoogle Scholar
  16. 16.
    D. A. Spandidos and N. M. Wilkie, Malignant transformation of early passage rodent cells by a single mutated human oncogene, Nature 310:469–475 (1984).PubMedCrossRefGoogle Scholar
  17. 17.
    H. Land, L. F. Parada, and R. A. Weinberg, Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes, Nature 304:596–602 (1983).PubMedCrossRefGoogle Scholar
  18. 18.
    M. Oshimura, T. Gilmer, and J. C. Barrett, Nonrandom loss of chromosome 15 in Syrian hamster tumors induced by v-Ha-ras plus v-myc oncogenes, Nature 316:636–639 (1985).PubMedCrossRefGoogle Scholar
  19. 19.
    M. Oshimura, M. Koi, N. Ozawa, O. Sugawara, P. W. Lamb, and J. C. Barrett, Role of chromosome loss in ras/myc-induced Syrian hamster tumors, Cancer Res. 48:1623–1632 (1988).PubMedGoogle Scholar
  20. 20.
    R. M. Kitchen and R. Sager, Genetic analysis of tumorigenesis: VI. Chromosome rearrangements in tumors derived from diploid premalignant Chinese hamster cells in nude mice, Somat. Cell Genet. 6:615–629 (1980).CrossRefGoogle Scholar
  21. 21.
    C. C. Lau, I. K. Gadi, S. Kalvonjian, A. Anisowicz, and R. Sager, Plasmid-induced “hit and run” tumorigenesis in Chinese hamster embryo fibroblast (CHEF) cells, Proc. Natl. Acad. Sci. USA 82:2839–2843 (1985).PubMedCrossRefGoogle Scholar
  22. 22.
    B. E. Weissman, Suppression of tumorigenicity in mammalian cell hybrids, in: “Mechanisms of Environmental Carcinogenesis, Vol. I, Epigenetic Changes,” J. C. Barrett, ed. CRC Press, Boca Raton (1987).Google Scholar
  23. 23.
    B. Ephrussi, “Hybridization of Somatic Cells,” Princeton University Press, Princeton (1972).Google Scholar
  24. 24.
    G. Barski, S. Sorieul, Fr. Cornefurt, Production dans des cultures in vitro de deux souches cellulaires en association de cellules de caractere “hybrid”, C. R. Acad. Sci. 251:1825–1827 (1960).Google Scholar
  25. 25.
    H. Harris, O. J. Miller, G. Klein, P. Worst, and T. Tachibana, Suppression of malignancy by cell fusion, Nature 223:363–368 (1969).PubMedCrossRefGoogle Scholar
  26. 26.
    H. Harris, Cell fusion and the analysis of malignancy, Proc. Roy. Soc. Lond. B. Biol. Sci. 179:1–20 (1971).CrossRefGoogle Scholar
  27. 27.
    E. J. Stanbridge, Suppression of malignancy in human cells, Nature 260:17–21 (1976).PubMedCrossRefGoogle Scholar
  28. 28.
    E. J. Stanbridge, C. J. Der, C. J. Doersen, R. Y. Nishimi, D. M. Peehl, B. E. Weissman, and J. Wilkinson, Human cell hybrids: analysis of transformation and tumorigenicity, Science 215:252–259 (1982).PubMedCrossRefGoogle Scholar
  29. 29.
    E. J. Stanbridge, R. R. Flandermyer, F. W. Daniels, and W. A. Nelson-Rees, Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids, Somat. Cell Genet. 7:699–712 (1981).PubMedCrossRefGoogle Scholar
  30. 30.
    H. P. Klinger and T. B. Shows, Suppression of tumorigenicity in somatic cell hybrids, II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells, J. Nat. Cancer Inst. 71:559–569 (1983).PubMedGoogle Scholar
  31. 31.
    P. J. Saxon, E. S. Srivarsan, and E. J. Stanbridge, Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells, EMBO J. 5:3461–3466 (1986).PubMedGoogle Scholar
  32. 32.
    B. E. Weissman, P. J. Saxon, S. R. Pasquale, G. R. Jones, A. G. Geiser, and E. J. Stanbridge, Introduction of a normal human chromosome 11 into a Wilms’ tumor cell line controls its tumorigenic expression, Science 236:175–180 (1987).PubMedCrossRefGoogle Scholar
  33. 33.
    A. G. Knudson, Hereditary cancer, oncogenes, and antioncogenes, Cancer Res. 45:1437–1443 (1985).PubMedGoogle Scholar
  34. 34.
    A. G. Knudson, Mutation and cancer: statistical study of retinoblastoma, Proc. Natl. Acad. Sci. USA 68:820–823 (1971).PubMedCrossRefGoogle Scholar
  35. 35.
    A. G. Knudson, Retinoblastoma: a prototypic hereditary neoplasm, Semin. Oncol. 5:57–60 (1978).PubMedGoogle Scholar
  36. 36.
    A. G. Knudson, Model hereditary cancers of man, Prog. Nucl. Acids Res. Mol. Biol. 29:17–25 (1983).CrossRefGoogle Scholar
  37. 37.
    W. K. Cavenee, T. P. Dryja, R. A. Phillips, W. F. Benedict, R. Godbout, B. L. Gallie, A. L. Murphree, L. C. Strong, and R. L. White, Expression of recessive alleles by chromosomal mechanisms in retinoblastoma, Nature 305:779–784 (1983).PubMedCrossRefGoogle Scholar
  38. 38.
    W. G. Benedict, A. Banerjee, C. Mark, and A. L. Murphree, Nonrandom chromosomal changes in untreated retinoblastomas, Cancer Genet. Cytogenet. 10:311–333 (1983).PubMedCrossRefGoogle Scholar
  39. 39.
    E. Chaum, R. M. Ellsworth, D. H. Abramson, B. G. Haik, F. D. Kitchin, and R. S. K. Chaganti, Cytogenetic analysis of retinoblastoma: evidence for multifocal origin and in vivo gene amplification, Cytogenet. Cell Genet. 38:82–91 (1984).PubMedCrossRefGoogle Scholar
  40. 40.
    A. L. Murphree and W. F. Benedict, Retinoblastoma: clues to human oncogenesis, Science 223:1028–1033 (1984).PubMedCrossRefGoogle Scholar
  41. 41.
    S. H. Friend, R. Bernards, S. Rogelj, R. A. Weinberg, J. M. Rapaport, D. M. Albert, and T. P. Dryja, A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma, Nature 323:643–646 (1986).PubMedCrossRefGoogle Scholar
  42. 42.
    W.-H. Lee, R. Bookstein, F. Hong, L.-J. Young, J.-Y. Shew, and E. Y.-H. P. Lee, Human retinoblastoma susceptibility gene: cloning, identification, and sequence, Science 235:1394–1399 (1987).PubMedCrossRefGoogle Scholar
  43. 43.
    A. D. Goddard, H. Balakier, M. Canton, J. Dunn, J. Squire, E. Reyes, A. Becker, R. A. Phillips, and B. L. Gallie, Infrequent genomic rearrangement and normal expression of the putative RB1 gene in retinoblastoma tumors, Molec. Cell. Biol. 8:2082–2088 (1988).PubMedGoogle Scholar
  44. 45.
    J. L. Dunn, R. A. Phillips, A. J. Becker, and B. L. Gallie, Identification of germline and somatic mutations affecting the retinoblastoma gene, Science 241:1797–1800 (1988).PubMedCrossRefGoogle Scholar
  45. 46.
    W.-H. Lee, J.-Y. Shew, F. D. Hong, T. W. Sery, L. A. Donoso, L.-J. Young, R. Bookstein, and E. Y.-H. P. Lee, The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity, Nature 329:642–645 (1987).PubMedCrossRefGoogle Scholar
  46. 47.
    A. T’Ang, J. M. Varley, S. Chakraborty, A. L. Murphree, and Y.-K. T. Fung, Structural rearrangement of the retinoblastoma gene in human breast carcinoma, Science 242:263–266 (1988).PubMedCrossRefGoogle Scholar
  47. 48.
    J. W. Harbour, S.-L. Lai, J. Whang-Peng, A. D. Gazdar, J. D. Minna, and F. J. Kaye, Abnormalities in structure and expression of the human retinoblastoma gene in SCLC, Science 241:353–357 (1988).PubMedCrossRefGoogle Scholar
  48. 49.
    J. Yokota, M. Wada, Y. Shimasato, M. Terada, and T. Sugimura, Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 of adenocarcinoma of the lung, Proc. Natl. Acad. Sci. USA 84:9252–9256 (1987).PubMedCrossRefGoogle Scholar
  49. 50.
    I. U. Ali, R. Lidereau, C. Theillet, and R. Callahan, Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia, Science 238:185–188 (1987).PubMedCrossRefGoogle Scholar
  50. 51.
    D. J. Law, S. Olschwang, J.-P. Monpezat, D. Lefrancois, D. Jagelman, N. J. Petrelli, G. Thomas, and A. P. Feinberg, Concerted nonsystemic allelic loss in human colorectal carcinoma, Science 241:961–965 (1987).CrossRefGoogle Scholar
  51. 52.
    R. Sager, Genetic suppression of tumor formation: A new frontier in cancer research, Cancer Res. 46:1573–1580 (1986).PubMedGoogle Scholar
  52. 53.
    D. M. Peehl and E. J. Stanbridge, Characterization of human keratinocyte × HeLa somatic cell hybrids, Int. J. Cancer 27:625–635 (1981).PubMedCrossRefGoogle Scholar
  53. 54.
    H. Harris and M. E. Bramwell, The suppression of malignancy by terminal differentiation: evidence from hybrids between tumor cells and keratinocytes, J. Cell Sci. 87:383–388 (1987).PubMedGoogle Scholar
  54. 55.
    M. Koi and J. C. Barrett, Loss of tumor suppression function during chemically induced neoplastic progression of Syrian hamster embryo cells, Proc. Natl. Acad. Sci. USA 83:5992–5996 (1986).PubMedCrossRefGoogle Scholar
  55. 56.
    O. M. Pereira-Smith and J. R. Smith, Evidence for the recessive nature of cellular immortality, Science 221:963–966 (1983).CrossRefGoogle Scholar
  56. 57.
    C. K. Lumpkin, J. K. McClung, O. M. Pereira-Smith, and J. R. Smith, Existence of high abundance antiproliferative rnRNA’s in senescent human diploid fibroblasts, Science 232:393–395 (1986).PubMedCrossRefGoogle Scholar
  57. 58.
    J. Keski-Oja and H. L. Moses, Growth inhibitory peptides in the regulation of cell proliferation, Med. Biol. 65:13–20 (1987).PubMedGoogle Scholar
  58. 59.
    C. Knabbe, M. E. Lippman, L. M. Wakefield, K. C. Flanders, A. Kasid, R. Derynck, and R. B. Dickson, Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells, Cell 48:417–428 (1987).PubMedCrossRefGoogle Scholar
  59. 60.
    R. W. Wiseman, M. E. Lambert, P. W. Lamb, J. I. Garrels, and J. C. Barrett, Alterations in gene expression at various stages of neoplastic transformation of Syrian hamster embryo (SHE) cells, J. Cell. Biochem. Supplement 12A:219 (1988).Google Scholar
  60. 61.
    F. Matsumura and S. Yamashiro-Matsumura, Purification and characterization of multiple isoforms of tropomyosin from rat cultured cells, J. Biol. Chem. 260:13851–13859 (1985).PubMedGoogle Scholar
  61. 62.
    L. B. Smillie, Structure and functions of tropomyosins from non-muscle sources, Trends Biochem. Sci. 4:151–155 (1979).CrossRefGoogle Scholar
  62. 63.
    G. P. Cote, Structural and functional properties of non-muscle tropomyosins, Molec. Cell. Biochem. 57:127–146 (1983).PubMedCrossRefGoogle Scholar
  63. 64.
    H. L. Cooper, N. Feuerstein, M. Noda, and R. H. Bassin, Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes, Molec. Cell. Biol. 5:972–983 (1985).PubMedGoogle Scholar
  64. 65.
    F. Matsumura and S. Yamashiro-Matsumura, Tropomyosin in cell transformation, Cancer Rev. 6:21–39 (1986).Google Scholar
  65. 66.
    J. C. Barrett, R. W. Wiseman, and J. A. Boyd, Ultrastructural changes in actin microfilaments which correlate with loss of the tumor suppressor phenotype in Syrian hamster embryo (SHE) cells, J. Cell Biol. 107:684a (1988).Google Scholar
  66. 67.
    L. Kopelovich, S. Conlon, and R. Pollack, Defective organization of actin in cultured skin fibroblasts from patients with inherited adenocarcinoma, Proc. Natl. Acad. Sci. USA 74:3019–3022 (1977).PubMedCrossRefGoogle Scholar
  67. 68.
    M. H. Antecol, A. Darveau, N. Sonenberg, and B. B. Mukherjee, Altered biochemical properties of actin in normal skin fibroblasts from individuals predisposed to dominantly inherited cancers, Cancer Res. 46:1867–1873 (1986).PubMedGoogle Scholar
  68. 69.
    N. Bouck, A. Stoler, and P. J. Polverini, Coordinate control of anchorage independence, actin cytoskeleton, and angiogenesis by human chromosome 1 in hamster-human hybrids, Cancer Res. 46:5101–5105 (1986).PubMedGoogle Scholar
  69. 70.
    M. Koi, C. A. Jones, L. A. Annab, and J. C. Barrett, Loss of a tumor suppressor gene function results in enhanced growth responsiveness of hamster cells in agar, Submitted for publication (1989).Google Scholar
  70. 71.
    J. A. Boyd, C. A. Jones, P. A. Futreal, and J. C. Barrett, Alterations in signal transduction which correlates with loss of the tumor suppressor phenotype in Syrian hamster embryo (SHE) cells, J. Cell Biol. 107:264a (1988).Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Jeff A. Boyd
    • 1
  • J. Carl Barrett
    • 1
  1. 1.Laboratory of Molecular CarcinogenesisNational Institute of Environmental Health SciencesResearch Triangle ParkUSA

Personalised recommendations